Gastric Intestinal Metaplasia in an Underserved Population in the USA: Prevalence, Epidemiologic and Clinical Features

被引：14

作者：

Almouradi, Tarek ^{[1
]}

Hiatt, Tadd ^{[1
]}

Attar, Bashar ^{[1
]}

机构：

[1] John H Stroger Hosp Cook Cty, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60612 USA

来源：

GASTROENTEROLOGY RESEARCH AND PRACTICE | 2013年 / 2013卷

关键词：

HELICOBACTER-PYLORI ERADICATION; SEQUENTIAL THERAPY; CANCER; RISK;

D O I：

10.1155/2013/856256

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Gastric intestinal metaplasia is an important stage in the development of gastric cancer. Limited data is available regarding the prevalence of gastric intestinal metaplasia in the United States. We conducted a retrospective review of esophagogastroduodenoscopies performed in our endoscopy unit between the months of April and October 2010 to evaluate the prevalence and the epidemiologic and endoscopic features of gastric intestinal metaplasia in an underserved population in the United States.

引用

页数：4

共 14 条

[1]

CORREA P, 1992, CANCER RES, V52, P6735

[2] INTESTINAL METAPLASIA AND HELICOBACTER-PYLORI - AN ENDOSCOPIC BIOPTIC STUDY OF THE GASTRIC ANTRUM [J].

CRAANEN, ME ;

DEKKER, W ;

BLOK, P ;

FERWERDA, J ;

TYTGAT, GNJ .

GUT, 1992, 33 (01) :16-20

[3] PREVALENCE OF INTESTINAL METAPLASIA IN HELICOBACTER-PYLORI GASTRITIS [J].

EIDT, S ;

STOLTE, M .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 (07) :607-610

[4]

FENNERTY MB, 1992, CANCER EPIDEM BIOMAR, V1, P293

[5] Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis [J].

Petersson, F ;

Borch, K ;

Franzén, LE .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (03) :262-266

[6] Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial [J].

Romano, Marco ;

Cuomo, Antonio ;

Gravina, Antonietta G. ;

Miranda, Agnese ;

Iovene, Maria Rosaria ;

Tiso, Angelo ;

Sica, Mariano ;

Rocco, Alba ;

Salerno, Raffaele ;

Marmo, Riccardo ;

Federico, Alessandro ;

Nardone, Gerardo .

GUT, 2010, 59 (11) :1465-1470

[7] Helicobacter pylori eradication with either seven-day or 10-day triple therapies, and with a 10-day sequential regimen [J].

Scaccianoce, G ;

Hassan, C ;

Panarese, A ;

Piglionica, D ;

Morini, S ;

Zullo, A .

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 20 (02) :113-117

[8] Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers [J].

Tulassay, Zsolt ;

Stolte, Manfred ;

Engstrand, Lars ;

Butruk, Eugeniusz ;

Malfertheiner, Peter ;

Dite, Petr ;

Tchernev, Konstantin ;

Wong, Benjamin C. Y. ;

Gottlow, Mattis ;

Eklund, Stefan ;

Wrangstadh, Michael ;

Herszenyi, Laszlo ;

Nagy, Peter .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (09) :1048-1058

[9] Helicobacter pylori infection and the development of gastric cancer. [J].

Uemura, N ;

Okamoto, S ;

Yamamoto, S ;

Matsumura, N ;

Yamaguchi, S ;

Yamakido, M ;

Taniyama, K ;

Sasaki, N ;

Schlemper, RJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (11) :784-789

[10] Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication -: A randomized trial [J].

Vaira, Dino ;

Zullo, Angelo ;

Vakil, Nimish ;

Gatta, Luigi ;

Ricci, Chiara ;

Perna, Federico ;

Hassan, Cesare ;

Bernabucci, Veronica ;

Tampieri, Andrea ;

Morini, Sergio .

ANNALS OF INTERNAL MEDICINE, 2007, 146 (08) :556-145

← 1 2 →